{"schema_version":"secwatch.filing_event.v1","accession":"0000046250-22-000034","form_type":"8-K","ticker":"HWKN","cik":"0000046250","company_name":"HAWKINS INC","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.217091+00:00","generated_at":"2026-06-22T15:46:14.035453+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Hawkins reports record Q2; sales up 32% to $241.2M, EPS $0.86 (+28%); guides Q3 flat YoY","bullets":["Sales $241.2M (+32% YoY); all three segments grew; Industrial +37%, Water Treatment +39%, Health & Nutrition +7%.","Net income $18.0M ($0.86 diluted EPS) vs $14.1M ($0.67) a year ago; adjusted EBITDA $34.0M (+28%).","LIFO expense of $5.3M in the quarter ($9.0M YTD) pressured gross margin to 19% vs 20% last year.","Operating cash flow $28.2M; paid down $18.5M on revolver; leverage ratio 1.26x EBITDA.","CEO expects Q3 EPS relatively flat due to supplier shutdown, LIFO pressures, and softness in Health & Nutrition."],"urls":{"canonical":"https://secwatch.observer/filing/0000046250-22-000034","json":"https://secwatch.observer/filing/0000046250-22-000034.json","markdown":"https://secwatch.observer/filing/0000046250-22-000034.md","text":"https://secwatch.observer/filing/0000046250-22-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/46250/000004625022000034/0000046250-22-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/46250/000004625022000034/hwkn-20221102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T15:46:14.035453+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"61ccf65bf12fe9cc66956d8c893991878d420498","claim":"HAWKINS INC reported fiscal 2023 second quarter ended October 2, 2022 results: revenue $241.2 million, net income $18.0 million, EPS $0.86 per diluted share.","evidence_excerpt":"income, net income, diluted earnings per share (EPS), adjusted EBITDA (earnings before interest, taxes, depreciation and amortization), and operating cash flow. • Sales of $241.2 million, a 32% year-over-year increase, with all three reporting segments growing over the same quarter in the prior year. • Gross profit of $46.4 million, a 24% increase over the prior","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/46250/000004625022000034/0000046250-22-000034-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal 2023 second quarter ended October 2, 2022"},{"label":"Revenue","value":"$241.2 million"},{"label":"Net income","value":"$18.0 million"},{"label":"EPS","value":"$0.86 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}